The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge.

RCMI Coordinating Center (RCMI CC)

The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge.

Norgard NB, Lopez-Candales A. The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge. Postgrad Med. 2022 01; 134(1):11-13.

View in: PubMed

subject areas

Cardiovascular Diseases
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2

authors with profiles

Angel Lopez-Candales

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support